Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.450
+0.121 (9.09%)
At close: Aug 27, 2025, 4:00 PM
1.490
+0.040 (2.76%)
After-hours: Aug 27, 2025, 6:49 PM EDT

Enveric Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2020
Selling, General & Admin
5.96.458.8511.7319.885.32
Upgrade
Research & Development
3.782.847.257.914.760.17
Upgrade
Operating Expenses
9.969.6316.4519.9625.295.62
Upgrade
Operating Income
-9.96-9.63-16.45-19.96-25.29-5.62
Upgrade
Interest Expense
-0---0.01-0.01-0.45
Upgrade
Interest & Investment Income
-00---
Upgrade
Other Non Operating Income (Expenses)
0.030.07-0.827.468.2-0.8
Upgrade
EBT Excluding Unusual Items
-9.94-9.57-17.26-12.5-17.1-6.86
Upgrade
Merger & Restructuring Charges
-----0.65-
Upgrade
Impairment of Goodwill
----1.49-8.23-
Upgrade
Asset Writedown
----5.97-30.45-
Upgrade
Pretax Income
-9.94-9.57-17.26-19.96-56.43-6.86
Upgrade
Income Tax Expense
0.010.010.03-1.49-7.45-
Upgrade
Net Income
-9.94-9.57-17.29-18.47-48.98-6.86
Upgrade
Preferred Dividends & Other Adjustments
--0.170.33--
Upgrade
Net Income to Common
-9.94-9.57-17.46-18.8-48.98-6.86
Upgrade
Shares Outstanding (Basic)
11000-
Upgrade
Shares Outstanding (Diluted)
11000-
Upgrade
Shares Change (YoY)
425.68%249.39%49.31%206.13%--
Upgrade
EPS (Basic)
-7.08-19.04-121.29-195.02-1555.32-
Upgrade
EPS (Diluted)
-7.08-19.04-121.29-195.02-1555.32-
Upgrade
Free Cash Flow
-6.52-7.73-14.1-17.73-11.65-3.89
Upgrade
Free Cash Flow Per Share
-4.64-15.36-97.96-183.93-369.88-
Upgrade
EBITDA
-9.68-9.29-16.1-19.63-24.64-5.5
Upgrade
D&A For EBITDA
0.290.340.340.330.660.12
Upgrade
EBIT
-9.96-9.63-16.45-19.96-25.29-5.62
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q